Skip to main content
. 2018 Feb 5;14(2):204–216. doi: 10.7150/ijbs.22955

Figure 1.

Figure 1

Gaps between pre-clinical evaluation and clinical outcome when EGFR-TKi combined with chemotherapy/targeted therapy